| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 01/02/2004 | EP1373493A1 Coagulation factor vii derivatives |
| 01/02/2004 | EP1373489A2 Human dual specificity protein phosphatase 7-like protein |
| 01/02/2004 | EP1373477A2 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
| 01/02/2004 | EP1373310A2 Staphylococcus aureus proteins and nucleic acids |
| 01/02/2004 | EP1373301A2 Reducing the immunogenicity of fusion proteins |
| 01/02/2004 | EP1372718A2 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 01/02/2004 | EP1372418A2 Non-oligomerizing tandem fluorescent proteins |
| 01/01/2004 | US20040003425 Nav2 channel gene-deficient non-human animals |
| 01/01/2004 | US20040003417 Animals transgenic for a tetracycline-regulated transcriptional inhibitor |
| 01/01/2004 | US20040002585 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 01/01/2004 | US20040002455 Targeted immunogens |
| 01/01/2004 | US20040002449 METH1 and METH2 polynucleotides and polypeptides |
| 01/01/2004 | US20040002114 Nucleic acids encoding a G-protein coupled receptor involved in islet cell signaling |
| 01/01/2004 | US20040002088 Identification and isolation of novel DNA and to the recombinant production of polypeptides having sequence similarity to Glial Cell line-derived Neurotrophic Factor Receptor (GDNFR) |
| 01/01/2004 | US20040002057 Cloning vectors and methods for producing a library of DNA molecules capable of expressing a fusion polypeptide on the surface of a filamentous phage particle |
| 01/01/2004 | US20040001853 Genetic engineering; immunoglobulins; hepatitis virus ; induce immunology response |
| 01/01/2004 | US20040001840 Cancer-linked gene as target for chemotherapy |
| 01/01/2004 | US20040001790 Methods for diagnosis and treatment of tumours |
| 12/31/2003 | WO2004001068A2 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 12/31/2003 | WO2004001041A1 Expression vector, host, fused protein, process for producing fused protein and process for producing protein |
| 12/31/2003 | WO2004000875A2 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders |
| 12/31/2003 | WO2003064471A3 Gene for peripheral arterial occlusive disease |
| 12/31/2003 | WO2003057708A3 Fusion proteins |
| 12/31/2003 | WO2003045997A3 Fusion proteins containing tlp peptides |
| 12/31/2003 | WO2003020759A9 A caspase- 8 binding protein, its preparation and use |
| 12/31/2003 | WO2002097059B1 Chromosome-based platforms |
| 12/31/2003 | WO2002040671A3 Immunoglobulin superfamily proteins |
| 12/31/2003 | WO2002040650A3 Methods for large scale production of recombinant dna-derived tpa or k2s molecules |
| 12/31/2003 | WO2002038766A3 Human tumor necrosis factor receptor |
| 12/31/2003 | CN1464908A Multivalent antibodies and uses therefor |
| 12/31/2003 | CN1464790A T cell receptor fusions and conjugates and methods of use thereof |
| 12/31/2003 | CN1464058A Tumor-repressed fusion protein, its encoding gene and use thereof |
| 12/31/2003 | CN1463986A Type-S non-virus carrier and pharmaceutical composition containing the same |
| 12/31/2003 | CA2491803A1 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders |
| 12/31/2003 | CA2490384A1 Expression vector, host, fused protein, process for producing fused protein and process for producing protein |
| 12/31/2003 | CA2489024A1 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 12/30/2003 | US6670453 Crosslinking, agglutination, purification |
| 12/30/2003 | US6670167 Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof |
| 12/30/2003 | US6669938 ImmunoConjucates for cancer diagnosis and therapy |
| 12/25/2003 | WO2003106497A1 Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer |
| 12/25/2003 | US20030237101 Stem cell factor; modulation of gene expression |
| 12/25/2003 | US20030236390 Materials for the production of nanometer structures and use thereof |
| 12/25/2003 | US20030236209 Compositions and methods for the therapy and diagnosis of lung cancer |
| 12/25/2003 | US20030236193 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 12/25/2003 | US20030235899 Catalytic domain of the human effector cell cycle checkpoint protein kinase Chk1 materials and methods for identification of inhibitors thereof |
| 12/25/2003 | US20030235888 Therapy for bone defects |
| 12/25/2003 | US20030235594 Comprises major histocompatability complex I epitopes |
| 12/25/2003 | US20030235582 Anti-IGF-I receptor antibody |
| 12/25/2003 | US20030235557 Administering two viral vectors containing an immunogenic portion of a wilms' tumor (wt1) polynucleotide operably linked to an expression control sequence |
| 12/24/2003 | WO2003106691A1 POLYPEPTIDES HAVING alpha- H-alpha-AMINO ACID AMIDE RACEMASE ACTIVITY AND NUCLEIC ACIDS ENCODING THE SAME |
| 12/24/2003 | WO2003106621A2 Anti-igf-i receptor antibody |
| 12/24/2003 | WO2003106501A1 Fusion protein comprising angiopoietin receptor-binding and a multimerization domain |
| 12/24/2003 | WO2003106488A2 Novel antagonists of cxcr3-binding cxc chemokines |
| 12/24/2003 | WO2003106487A1 Immunogenic conjugates |
| 12/24/2003 | WO2003055917A3 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 12/24/2003 | WO2003045429A3 Anti-t cell immunotoxin fusion protein and its therapeutic use |
| 12/24/2003 | WO2003022990A3 Production of fusion proteins and use for identifying binding molecules |
| 12/24/2003 | WO2002090542A3 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 12/24/2003 | WO2002088170A3 Cripto blocking antibodies and uses thereof |
| 12/24/2003 | WO2002068676A3 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 12/24/2003 | WO2002057435A3 Bifunctional fusion proteins with glucocerebrosidase activity |
| 12/24/2003 | CA2489724A1 Immunogenic conjugates |
| 12/24/2003 | CA2489469A1 Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer |
| 12/24/2003 | CA2489440A1 Anti-igf-i receptor antibody |
| 12/24/2003 | CA2486649A1 Fusion protein comprising angiopoietin receptor-binding and a multimerization domain |
| 12/23/2003 | US6667162 Isolating the Fkhsf polypeptide from cultured recombinant host cells. |
| 12/18/2003 | WO2003104807A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 12/18/2003 | WO2003104428A2 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 12/18/2003 | WO2003104282A2 Immunoadhesin comprising a glycoprotein vi domain |
| 12/18/2003 | WO2003103662A2 Inhibitors of glycoprotein vi |
| 12/18/2003 | WO2003103605A2 Flexible vaccine assembly and vaccine delivery platform |
| 12/18/2003 | WO2003103577A2 Novel recombinant anticoagulant proteins |
| 12/18/2003 | WO2003051917A3 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 12/18/2003 | WO2002058723A3 Chemokines as adjuvants of immune response |
| 12/18/2003 | WO2001034829A3 Nucleic acid sequence which encodes for an amino acid sequence capable of being cyclized within a cell or cell membrane |
| 12/18/2003 | US20030232755 Antitumor agents, anticarcinogenic agents, replacing another amino acid at 86, 87, and 88 of the amino acid sequence |
| 12/18/2003 | US20030232349 Nucleic acid and amino acid sequences of proteases and the use of these sequences in the diagnosis and treatment of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, and neurological disorders |
| 12/18/2003 | CA2488682A1 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 12/18/2003 | CA2487924A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 12/18/2003 | CA2486362A1 Novel recombinant anticoagulant proteins |
| 12/18/2003 | CA2486118A1 Flexible vaccine assembly and vaccine delivery platform |
| 12/17/2003 | EP1371730A2 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 12/17/2003 | EP1370676A2 Mouse cytokine receptor |
| 12/17/2003 | EP1370661A2 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 12/17/2003 | EP1370654A2 Chimpanzee erythropoietin (chepo) immunoadhesins |
| 12/17/2003 | EP1370588A2 Human monoclonal antibodies to fc alpha receptor (cd89) |
| 12/17/2003 | EP1370583A1 Polypeptides and nucleic acids for bolekine |
| 12/17/2003 | EP1370580A2 A new essential downstream component of the wingless signalling pathway |
| 12/17/2003 | EP1370579A1 Matrix gene expression in chondrogenesis |
| 12/17/2003 | EP1370286A1 Compositions of multimeric profilin for diagnosis and treatment of allergies |
| 12/17/2003 | CN1461753A H-type non virus carrier and medicinal compound containing same |
| 12/16/2003 | US6664077 DNA encoding ACPL |
| 12/16/2003 | US6664068 Antibodies, antiapoptotic agents |
| 12/16/2003 | US6663868 Heat shock protein-based vaccines and immunotherapies |
| 12/11/2003 | WO2003102584A2 Semaphorin-like proteins and methods of using same |
| 12/11/2003 | WO2003102187A1 Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence |
| 12/11/2003 | WO2003102177A1 METHOD OF SCREENING COMPOUND AFFECTING AMYLOID β PRODUCTION |
| 12/11/2003 | WO2003102157A2 Synthetic antibody phage libraries |
| 12/11/2003 | WO2003102154A2 Improved receptor detection |
| 12/11/2003 | WO2003101485A1 Cd16a binding proteins and use for the treatment of immune disorders |